<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3294129/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Novel Genetic Markers of Breast Cancer Survival Identified by a Genome-Wide Association Study</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294129/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Cancer Research"><meta name="citation_title" content="Novel Genetic Markers of Breast Cancer Survival Identified by a Genome-Wide Association Study"><meta name="citation_authors" content="Xiao Ou Shu, Jirong Long, Wei Lu, Chun Li, Wendy Y. Chen, Ryan Delahanty, Jiarong Cheng, Hui Cai, Ying Zheng, Jiajun Shi, Kai Gu, Wen-Jing Wang, Peter Kraft, Yu-Tang Gao, Qiuyin Cai, Wei Zheng"><meta name="citation_date" content="1 March 2012"><meta name="citation_issue" content="5"><meta name="citation_volume" content="72"><meta name="citation_firstpage" content="1182"><meta name="citation_doi" content="10.1158/0008-5472.CAN-11-2561"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3294129/?report=abstract"><meta name="citation_pmid" content="22232737"><meta name="DC.Title" content="Novel Genetic Markers of Breast Cancer Survival Identified by a Genome-Wide Association Study"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Xiao Ou Shu"><meta name="DC.Contributor" content="Jirong Long"><meta name="DC.Contributor" content="Wei Lu"><meta name="DC.Contributor" content="Chun Li"><meta name="DC.Contributor" content="Wendy Y. Chen"><meta name="DC.Contributor" content="Ryan Delahanty"><meta name="DC.Contributor" content="Jiarong Cheng"><meta name="DC.Contributor" content="Hui Cai"><meta name="DC.Contributor" content="Ying Zheng"><meta name="DC.Contributor" content="Jiajun Shi"><meta name="DC.Contributor" content="Kai Gu"><meta name="DC.Contributor" content="Wen-Jing Wang"><meta name="DC.Contributor" content="Peter Kraft"><meta name="DC.Contributor" content="Yu-Tang Gao"><meta name="DC.Contributor" content="Qiuyin Cai"><meta name="DC.Contributor" content="Wei Zheng"><meta name="DC.Date" content="2012 Mar 1"><meta name="DC.Identifier" content="10.1158/0008-5472.CAN-11-2561"><meta name="DC.Language" content="en"><meta property="og:title" content="Novel Genetic Markers of Breast Cancer Survival Identified by a Genome-Wide Association Study"><meta property="og:type" content="article"><meta property="og:description" content="Only two genome-wide association studies (GWAS) have been conducted to date to identify potential markers for total mortality after diagnosis of breast cancer. Here we report the identification of two SNPs associated with total mortality from a two-stage ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294129/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3294129/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3294129/pdf/nihms349335.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8DCF04DD53B98100000000020B015C.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3294129%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed">PubMed</option><option value="nuccore">Nucleotide</option><option value="gquery" class="last">All Databases</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC3294129</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Cancer Res</a></span>. Author manuscript; available in PMC 2013 Mar 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=22232737" target="pmc_ext" ref="reftype=publisher&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access"><span class="cit">Cancer Res. 2012 Mar 1; 72(5): 1182–1189. </span></a></div><span class="fm-vol-iss-date">Published online 2012 Jan 9. </span> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1158%2F0008-5472.CAN-11-2561" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1158/0008-5472.CAN-11-2561</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3294129</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS349335</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/22232737">22232737</a></div></div></div></div><h1 class="content-title">Novel Genetic Markers of Breast Cancer Survival Identified by a Genome-Wide Association Study</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Shu%20XO%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737" class="affpopup" co-rid="_co_idm140146812339536" co-class="co-affbox">Xiao Ou Shu</a>,<sup>1,</sup><sup>*</sup> <a href="/pubmed/?term=Long%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737" class="affpopup" co-rid="_co_idm140146744096560" co-class="co-affbox">Jirong Long</a>,<sup>1</sup> <a href="/pubmed/?term=Lu%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737" class="affpopup" co-rid="_co_idm140146744094896" co-class="co-affbox">Wei Lu</a>,<sup>2</sup> <a href="/pubmed/?term=Li%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737" class="affpopup" co-rid="_co_idm140146744092672" co-class="co-affbox">Chun Li</a>,<sup>3</sup> <a href="/pubmed/?term=Chen%20WY%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737" class="affpopup" co-rid="_co_idm140146744090448" co-class="co-affbox">Wendy Y. Chen</a>,<sup>4,</sup><sup>5</sup> <a href="/pubmed/?term=Delahanty%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737" class="affpopup" co-rid="_co_idm140146740308240" co-class="co-affbox">Ryan Delahanty</a>,<sup>1</sup> <a href="/pubmed/?term=Cheng%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737" class="affpopup" co-rid="_co_idm140146740306016" co-class="co-affbox">Jiarong Cheng</a>,<sup>6</sup> <a href="/pubmed/?term=Cai%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737" class="affpopup" co-rid="_co_idm140146740303792" co-class="co-affbox">Hui Cai</a>,<sup>1</sup> <a href="/pubmed/?term=Zheng%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737" class="affpopup" co-rid="_co_idm140146740301568" co-class="co-affbox">Ying Zheng</a>,<sup>2</sup> <a href="/pubmed/?term=Shi%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737" class="affpopup" co-rid="_co_idm140146812768448" co-class="co-affbox">Jiajun Shi</a>,<sup>1</sup> <a href="/pubmed/?term=Gu%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737" class="affpopup" co-rid="_co_idm140146812766224" co-class="co-affbox">Kai Gu</a>,<sup>2</sup> <a href="/pubmed/?term=Wang%20WJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737" class="affpopup" co-rid="_co_idm140146812764000" co-class="co-affbox">Wen-Jing Wang</a>,<sup>2</sup> <a href="/pubmed/?term=Kraft%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737" class="affpopup" co-rid="_co_idm140146739199056" co-class="co-affbox">Peter Kraft</a>,<sup>7</sup> <a href="/pubmed/?term=Gao%20YT%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737" class="affpopup" co-rid="_co_idm140146739196832" co-class="co-affbox">Yu-Tang Gao</a>,<sup>6</sup> <a href="/pubmed/?term=Cai%20Q%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737" class="affpopup" co-rid="_co_idm140146739194608" co-class="co-affbox">Qiuyin Cai</a>,<sup>1</sup> and  <a href="/pubmed/?term=Zheng%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737" class="affpopup" co-rid="_co_idm140146739192384" co-class="co-affbox">Wei Zheng</a><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140146812339536"><h3 class="no_margin">Xiao Ou Shu</h3><p><sup>1</sup>Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, Suite 600, IMPH, Nashville, TN, 37203-1738, USA</p><div>Find articles by <a href="/pubmed/?term=Shu%20XO%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737">Xiao Ou Shu</a></div></div><div id="_co_idm140146744096560"><h3 class="no_margin">Jirong Long</h3><p><sup>1</sup>Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, Suite 600, IMPH, Nashville, TN, 37203-1738, USA</p><div>Find articles by <a href="/pubmed/?term=Long%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737">Jirong Long</a></div></div><div id="_co_idm140146744094896"><h3 class="no_margin">Wei Lu</h3><p><sup>2</sup>Shanghai Center for Disease Control and Prevention, 1380 Zhong Shan Road W, Shanghai 200336, People’s Republic of China</p><div>Find articles by <a href="/pubmed/?term=Lu%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737">Wei Lu</a></div></div><div id="_co_idm140146744092672"><h3 class="no_margin">Chun Li</h3><p><sup>3</sup>Department of Biostatistics, Vanderbilt University School of Medicine, 1161 21<sup>st</sup> Avenue South, S-2323 Medical Center North, Nashville, TN 37232-2158, USA</p><div>Find articles by <a href="/pubmed/?term=Li%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737">Chun Li</a></div></div><div id="_co_idm140146744090448"><h3 class="no_margin">Wendy Y. Chen</h3><p><sup>4</sup>Channing Laboratory, Department of Medicine, Brigham &amp; Women’s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA</p><p><sup>5</sup>Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA</p><div>Find articles by <a href="/pubmed/?term=Chen%20WY%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737">Wendy Y. Chen</a></div></div><div id="_co_idm140146740308240"><h3 class="no_margin">Ryan Delahanty</h3><p><sup>1</sup>Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, Suite 600, IMPH, Nashville, TN, 37203-1738, USA</p><div>Find articles by <a href="/pubmed/?term=Delahanty%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737">Ryan Delahanty</a></div></div><div id="_co_idm140146740306016"><h3 class="no_margin">Jiarong Cheng</h3><p><sup>6</sup>Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China</p><div>Find articles by <a href="/pubmed/?term=Cheng%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737">Jiarong Cheng</a></div></div><div id="_co_idm140146740303792"><h3 class="no_margin">Hui Cai</h3><p><sup>1</sup>Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, Suite 600, IMPH, Nashville, TN, 37203-1738, USA</p><div>Find articles by <a href="/pubmed/?term=Cai%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737">Hui Cai</a></div></div><div id="_co_idm140146740301568"><h3 class="no_margin">Ying Zheng</h3><p><sup>2</sup>Shanghai Center for Disease Control and Prevention, 1380 Zhong Shan Road W, Shanghai 200336, People’s Republic of China</p><div>Find articles by <a href="/pubmed/?term=Zheng%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737">Ying Zheng</a></div></div><div id="_co_idm140146812768448"><h3 class="no_margin">Jiajun Shi</h3><p><sup>1</sup>Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, Suite 600, IMPH, Nashville, TN, 37203-1738, USA</p><div>Find articles by <a href="/pubmed/?term=Shi%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737">Jiajun Shi</a></div></div><div id="_co_idm140146812766224"><h3 class="no_margin">Kai Gu</h3><p><sup>2</sup>Shanghai Center for Disease Control and Prevention, 1380 Zhong Shan Road W, Shanghai 200336, People’s Republic of China</p><div>Find articles by <a href="/pubmed/?term=Gu%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737">Kai Gu</a></div></div><div id="_co_idm140146812764000"><h3 class="no_margin">Wen-Jing Wang</h3><p><sup>2</sup>Shanghai Center for Disease Control and Prevention, 1380 Zhong Shan Road W, Shanghai 200336, People’s Republic of China</p><div>Find articles by <a href="/pubmed/?term=Wang%20WJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737">Wen-Jing Wang</a></div></div><div id="_co_idm140146739199056"><h3 class="no_margin">Peter Kraft</h3><p><sup>7</sup>Department of Epidemiology, Harvard School of Public Health, 377 Huntington Avenue, Boston, MA 02115, USA</p><div>Find articles by <a href="/pubmed/?term=Kraft%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737">Peter Kraft</a></div></div><div id="_co_idm140146739196832"><h3 class="no_margin">Yu-Tang Gao</h3><p><sup>6</sup>Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China</p><div>Find articles by <a href="/pubmed/?term=Gao%20YT%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737">Yu-Tang Gao</a></div></div><div id="_co_idm140146739194608"><h3 class="no_margin">Qiuyin Cai</h3><p><sup>1</sup>Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, Suite 600, IMPH, Nashville, TN, 37203-1738, USA</p><div>Find articles by <a href="/pubmed/?term=Cai%20Q%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737">Qiuyin Cai</a></div></div><div id="_co_idm140146739192384"><h3 class="no_margin">Wei Zheng</h3><p><sup>1</sup>Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, Suite 600, IMPH, Nashville, TN, 37203-1738, USA</p><div>Find articles by <a href="/pubmed/?term=Zheng%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22232737">Wei Zheng</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140146777078896_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140146777078896_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140146777078896_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>1</sup>Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, Suite 600, IMPH, Nashville, TN, 37203-1738, USA</div><div class="fm-affl" id="A2" lang="en"><sup>2</sup>Shanghai Center for Disease Control and Prevention, 1380 Zhong Shan Road W, Shanghai 200336, People’s Republic of China</div><div class="fm-affl" id="A3" lang="en"><sup>3</sup>Department of Biostatistics, Vanderbilt University School of Medicine, 1161 21<sup>st</sup> Avenue South, S-2323 Medical Center North, Nashville, TN 37232-2158, USA</div><div class="fm-affl" id="A4" lang="en"><sup>4</sup>Channing Laboratory, Department of Medicine, Brigham &amp; Women’s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA</div><div class="fm-affl" id="A5" lang="en"><sup>5</sup>Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA</div><div class="fm-affl" id="A6" lang="en"><sup>6</sup>Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China</div><div class="fm-affl" id="A7" lang="en"><sup>7</sup>Department of Epidemiology, Harvard School of Public Health, 377 Huntington Avenue, Boston, MA 02115, USA</div><div id="cor1"><sup>*</sup><strong>Corresponding Author:</strong> Xiao Ou Shu, M.D., Ph.D., Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, Suite 600, IMPH, Nashville, TN, 37203-1738, USA; Tel: 615-936-0713; Fax: 615-936-8291; <a href="mailto:dev@null" data-email="ude.tlibrednav@uhs.uo-oaix" class="oemail">ude.tlibrednav@uhs.uo-oaix</a></div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140146777078896_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available free at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=22232737" target="pmc_ext" ref="reftype=publisher&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access">Cancer Res</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC3294129/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="2" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>1.</strong></div><div><a href="/pmc/articles/PMC3294129/bin/NIHMS349335-supplement-1.docx" data-ga-action="click_feat_suppl">NIHMS349335-supplement-1.docx</a><span style="color:gray"> (25K)</span></div><div class="small guid">GUID:&nbsp;A6047EB9-B164-4C2F-8847-9DD8E4E09129</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>2.</strong></div><div><a href="/pmc/articles/PMC3294129/bin/NIHMS349335-supplement-2.docx" data-ga-action="click_feat_suppl">NIHMS349335-supplement-2.docx</a><span style="color:gray"> (94K)</span></div><div class="small guid">GUID:&nbsp;13786198-F06A-4085-A4B5-353AA36DF296</div></div></dd></dl></div><div id="idm140146739591520" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140146739591520title">Abstract</h2><!--article-meta--><div><p id="P1" class="p p-first-last">Only two genome-wide association studies (GWAS) have been conducted to date to identify potential markers for total mortality after diagnosis of breast cancer. Here we report the identification of two SNPs associated with total mortality from a two-stage GWAS conducted among 6,110 Shanghai-resident Chinese women with TNM stage I-IV breast cancer. The discovery stage included 1,950 patients and evaluated 613,031 common SNPs. The top 49 associations were evaluated in an independent replication stage of 4,160 Shanghai breast cancer patients. A consistent and highly significant association with total mortality was documented for SNPs rs3784099 and rs9934948. SNP rs3784099, located in the <em>RAD51L1</em> gene, was associated with total morality in both the discovery stage (<em>P</em>=1.44×10<sup>−8</sup>) and replication stage (<em>P</em>=0.06; <em>P</em>-combined=1.17×10<sup>−7</sup>). Adjusted hazard ratios (HR) for total mortality were 1.41 (95%CI=1.18–1.68) for the <em>AG</em> genotype and 2.64 (95%CI=1.74–4.03) for the <em>AA</em> genotype, when compared with the GG genotype. The variant <em>C</em> allele of rs9934948, located on chromosome 16, was associated with a similarly elevated risk of total mortality (<em>P</em>-combined: 5.75×10<sup>−6</sup>). We also observed this association among 1,145 breast cancer patients of European-ancestry from the Nurses’ Health Study (NHS; <em>P</em>=0.006); the association was highly significant in a combined analysis of NHS and Chinese data (P=1.39×10<sup>−7</sup>). Similar associations were observed for these two SNPs with breast cancer-specific mortality. This study provides strong evidence suggesting that the <em>RAD51L1</em> gene and a chromosome 16 locus influence breast cancer prognosis.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">breast cancer, survival, genome-wide association study, Asian population, <em>RAD51L1</em> gene</span></div></div><div id="S1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S1title">INTRODUCTION</h2><p id="P2" class="p p-first">Breast cancer is one of the most common malignancies among women in many countries, including China. Despite generally good prognosis for breast cancer patients, wide variation exists in survival, even after accounting for clinical prognostic factors, suggesting that genetic susceptibility may influence breast cancer outcomes. Over the past 10 years, candidate-gene studies, including our own (<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879835">1</a>–<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879822">5</a>), have found several genetic variants to be related to breast cancer prognosis. These genetic variants are found primarily in breast cancer susceptibility genes (e.g., <em>BRCA1, BRCA2</em>, <em>TP53</em>) (<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879825">6</a>–<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879817">8</a>) or genes involved in drug metabolism (e.g., <em>CYP2D6, NQO1</em>) (<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879795">9</a>, <a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879813">10</a>) and tumor microenvironment regulation (e.g., <em>TGFβ1</em>, <em>VEGF</em>, <em>CCND1</em>, <em>PAI1</em>, <em>MMP7</em>) (<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879839">1</a>–<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879821">5</a>). However, very few of these associations have been confirmed. Given that almost all previous studies used the candidate-gene approach, in which only a limited number of genetic variants are investigated and the choice of variant is based on our limited knowledge of the underlying biology of cancer, more comprehensive genomic investigations of breast cancer prognosis are urgently needed. Recent genome-wide association studies (GWAS) have identified genetic variants related to breast cancer risk that have been robustly replicated across populations (<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879799">11</a>–<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879791">18</a>). Many GWAS-identified genetic markers are located in regions that had never been suspected of being related to cancer susceptibility. To our knowledge, only two studies have evaluated genetic factors in relation to breast cancer survival using the GWAS approach (<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879793">19</a>, <a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879809">20</a>) and both were conducted among women of European ancestry. The first study reported a single nucleotide polymorphism (SNP) in the <em>OCA2</em> gene (rs4778137) associated with total mortality among women of European ancestry with estrogen receptor (ER)-negative tumors at <em>P</em>=5×10<sup>−4</sup> (<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879814">19</a>). However, the second study, conducted as part of the Cancer Genetic Markers of Susceptibility (CGEMS) study, found no SNPs with a statistically significant association with breast cancer survival (<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879801">20</a>).</p><p id="P3" class="p p-last">Over the past 15 years, we have conducted multiple, large-scale, population-based studies of breast cancer among Chinese women in Shanghai (<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879798">14</a>, <a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879792">21</a>, <a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879812">22</a>). Using the data collected from these studies, we evaluated lifestyle determinants of breast cancer survival (<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879797">21</a>, <a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879806">23</a>, <a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879796">24</a>). In addition to the candidate-gene studies reported previously (<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879823">1</a>–<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879820">5</a>), we recently conducted a two-stage GWAS among 6,110 patients (719 deaths) with stage I to IV breast cancer recruited in the Shanghai studies to identify novel genetic variants associated with breast cancer survival. To evaluate the generalizability of our findings to other ethnic groups, we investigated these GWAS-identified SNPs in CGEMS data from 1,145 breast cancer patients (229 deaths) of European ancestry who participated in the Nurses’ Health Study (NHS).</p></div><div id="S2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S2title">METHODS</h2><div id="S3" class="sec sec-first"><h3 id="S3title">Overall Study Design and Study Populations</h3><p id="P4" class="p p-first">Samples included in this GWAS came from participants of the Shanghai Breast Cancer Study (SBCS) and Shanghai Breast Cancer Survival Study (SBCSS). Details on the methodology of the parent studies have been described previously (<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879802">14</a>, <a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879826">21</a>). Briefly, the SBCS is a population-based, case-control study that recruited incident breast cancer patients and controls in urban Shanghai between August 1996 and March 1998 and again between April 2002 and February 2005 (<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879808">14</a>). A total of 3,448 patients were recruited (participation rate: 86.7%); 90.6% of participants provided a blood or exfoliated buccal cell sample. The SBCSS also was conducted in urban Shanghai and recruited 5,042 breast cancer patients between March 2002 and April 2006 (participation rate: 80.1%); 98% of patients provided an exfoliated buccal cell sample (<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879800">14</a>, <a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879833">21</a>). All participants of both studies provided written informed consent before participating in the study and the Institutional Review Boards of all institutes involved approved the study protocols. Medical charts for breast cancer patients were reviewed to verify cancer diagnosis and obtain treatment information. Cancer patients have been followed for survival status and breast cancer recurrence through a combination of record linkages with the Shanghai Vital Statistics Registry and in-person surveys. Due to a time overlap during recruitment, 1,469 women participated in both the SBCS and SBCSS. After taking these overlaps into consideration and excluding patients with stage 0 disease (n=190), those for whom we had no information on survival status (n=185), and genotyping failures due to limited DNA (n=17), a total of 6,110 participants remained in the present study. The discovery stage of this study included 1,950 participants. Genomic DNA samples were genotyped primarily using the Affymetrix Genome-Wide Human SNP Array 6.0. From the discovery stage, two batches of SNPs were selected for replication in an independent set of samples from the Shanghai studies. Criteria used to select SNPs for validation were: 1) P&lt;=0.001 under the additive model for either the total mortality (overall survival) or breast cancer recurrence (disease-free survival) analysis; for SNPs that are on or close to metastasis genes or genes previous indicated in breast cancer prognosis, the P-value was relaxed to &lt;=0.01; 2) Minor allele frequency &gt;10%; 3) Exhibited high quality genotype cluster plots; 4) In regions where multiple SNPs in linkage disequilibrium (LD) (r<sup>2</sup>&gt;=0.6) met the above criteria, the SNP with the lowest P value was chosen. The first batch (the top 30 SNPs not in LD) was selected when GWAS data were available for 1,436 participants. Twenty-nine of these SNPs were successfully genotyped in an independent set of 3,881 Shanghai study participants. The second batch (the top 20 SNPs not in LD and not overlapping with those included in the first batch) was selected after an additional 514 breast cancer patients (for a total of 1,950 participants included in the discovery stage) were scanned. These 20 SNPs were genotyped in an independent set of 4,160 Shanghai study participants. Among women who participated in the two batches of validation studies, 3,522 overlapped.</p><p id="P5" class="p p-last">To explore the generalizability of the study findings to other ethnic groups, we selected eight SNPs with possible associations with breast cancer survival in the Shanghai studies and evaluated their associations with breast cancer survival in European-ancestry Americans using data from the CGEMS project. These SNPs were chosen based on the significance level of the association found in the discovery stage and/or the consistency of the associations observed in both discovery and replication stages. The CGEMS project included 1,145 post-menopausal breast cancer cases from the NHS whose DNA samples were scanned using the Illumina HumanHap500 array (<a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_301624830">12</a>, <a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879827">16</a>). The NHS is a prospective cohort of 121,700 registered nurses who resided in 11 US states and enrolled in the study in 1976. Follow-up was conducted by personal mailings and searches of the National Death Index (<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879831">20</a>).</p></div><div id="S4" class="sec"><h3 id="S4title">Genotyping and Quality Control Procedures</h3><p id="P6" class="p p-first">We included three positive quality control (QC) samples purchased from Coriell Cell Repositories (Coriell Institute, Camden, NJ, USA) and a negative QC sample (water) in each of the 96-well test plates. The average concordance among the QC samples was 99.85% (median: 100%). The gender of all scanned samples was confirmed. Genetically identical, unexpected duplicated samples were excluded, as were close relatives with a pairwise proportion of IBD estimate &gt;0.25. Multidimensional scaling (MDS) analyses of pooled data including 210 unrelated HapMap subjects, and our study data showed that all our study participants clustered closely with HapMap Asians. All samples with a call rate &lt;95% were excluded. In addition, each SNP met following inclusion criteria: 1) Minor allele frequency (MAF) ≥0.05; 2) Call rate ≥95%; 3) P for Hardy-Weinberg equilibrium (HWE) ≥0.000001; 4) concordance ≥95% among duplicated QC samples. After exclusions, 607,728 SNPs from batch 1 and 613,031 SNPs from batch 2 were available for the statistical analyses used to select promising SNPs for replication. The genotyping and QC protocols for the CGEMS project are described in detail elsewhere (<a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_301624831">12</a>, <a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879804">16</a>).</p><p id="P7" class="p p-last">Genotyping for the replication stage was performed on the iPLEX™ Sequenom MassARRAY® platform. Polymerase chain reaction (PCR) and extension primers were designed by using the MassARRAY Assay Design 3.0 software (Sequenom, Inc). PCR and extension reactions were performed according to the manufacturer’s instructions, and extension product sizes were determined by mass spectrometry using the Sequenom iPLEX system. In each 96-well plate, two negative controls (water), two blinded duplicates, and two samples from the HapMap project were included. The concordance was 100% for all SNPs for both the blinded duplicates and the HapMap samples. We also included 65 participants who were genotyped by using the Affymetrix 6.0 array on the Sequenom genotyping platform and found 100% consistency for data generated on these two platforms. All SNPs showed high call rates (&gt;95%).</p></div><div id="S5" class="sec sec-last"><h3 id="S5title">Statistical Analyses</h3><p id="P8" class="p p-first">A set of 4,305 SNPs (not in LD) with a MAF&gt;0.35 and at least 100kb apart was selected to evaluate the population structure. The inflation factor λ was estimated to be 1.045, suggesting that population substructure, if present, should not have any appreciable effect on the results.</p><p id="P9" class="p p-last">Outcomes of the study were total mortality (for the overall survival analysis) and breast cancer recurrence (for the disease-free analysis). For the overall survival analysis, follow-up time was calculated as the number of days between the date of cancer diagnosis and the date of death or date of last record linkage for survivors. For the disease-free survival analysis, follow-up time was calculated as the number of days between the date of cancer diagnosis and disease recurrence or date of last survey for women who did not have disease recurrence or die of breast cancer. For 62 women who died of breast cancer but were missing information on disease recurrence, we imputed the date for recurrence based on the TNM stage-specific recurrence rate estimated for the current study. The delayed-entry Cox proportional hazards regression models were used to derive hazard ratios (HR) for total mortality and breast cancer recurrence in association with each SNP with adjustment for age. Additional adjustments for known clinical predictors for breast cancer prognosis, including breast cancer stage (TNM), estrogen/progesterone receptor (ER/PR) status, ever use of chemotherapy, radiotherapy, and tamoxifen did not materially change the results. We also examined the influence of population substructure by adjusting for the first 5 principal components derived based on 196,471 SNPs with a pairwise LD of r<sup>2</sup>&lt;0.2 that were selected using PLINK (<a href="#R25" rid="R25" class=" bibr popnode">25</a>, <a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879807">26</a>). We observed no appreciable changes in study results (data not shown). Thus, the results presented in this article were not adjusted for population substructure.</p></div></div><div id="S6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S6title">RESULTS</h2><p id="P10" class="p p-first">Clinical characteristics of study participants are presented in <a href="/pmc/articles/PMC3294129/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>. Patients included in the discovery stage were younger, more like to have late-stage disease, lower 5-year survival rates, and to have received chemotherapy, radiotherapy, or tamoxifen than those included in the replication stage. These differences reflect differences in study enrollment criteria (the SBCS, contributed the majority of cases to the discovery stage and disproportionally recruited younger women with breast cancer) and, possibly, temporal changes in breast cancer treatment protocols and outcomes.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="P46">Demographic characteristics of participants of the Shanghai Breast Cancer Study (1996–2005) and Shanghai Breast Cancer Survival Study (2002–2006)</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140146739154576" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" align="left"></th><th rowspan="1" colspan="1" align="center">Discovery Stage</th><th rowspan="1" colspan="1" align="center">Replication Stage</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="left">No. of cases</td><td rowspan="1" colspan="1" align="center">1,950</td><td rowspan="1" colspan="1" align="center">4,160</td></tr><tr><td rowspan="1" colspan="1" align="left">Total no. of deaths</td><td rowspan="1" colspan="1" align="center">331</td><td rowspan="1" colspan="1" align="center">388</td></tr><tr><td rowspan="1" colspan="1" align="left">No. of recurrences</td><td rowspan="1" colspan="1" align="center">411</td><td rowspan="1" colspan="1" align="center">504</td></tr><tr><td rowspan="1" colspan="1" align="left">No. of breast cancer deaths</td><td rowspan="1" colspan="1" align="center">299</td><td rowspan="1" colspan="1" align="center">331</td></tr><tr><td rowspan="1" colspan="1" align="left">Age at diagnosis (median, range)</td><td rowspan="1" colspan="1" align="center">48.3 (22.6–69.9)</td><td rowspan="1" colspan="1" align="center">51.2 (20.4–75.0)</td></tr><tr><td rowspan="1" colspan="1" align="left">Year of follow-up (median)</td><td rowspan="1" colspan="1" align="center">6.1 (0.3–8.7)</td><td rowspan="1" colspan="1" align="center">3.7 (0.5–8.2)</td></tr><tr><td rowspan="1" colspan="1" align="left">TNM (%)</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;I</td><td rowspan="1" colspan="1" align="center">29.88</td><td rowspan="1" colspan="1" align="center">35.83</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;II</td><td rowspan="1" colspan="1" align="center">59.07</td><td rowspan="1" colspan="1" align="center">53.39</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;III</td><td rowspan="1" colspan="1" align="center">10.03</td><td rowspan="1" colspan="1" align="center">10.24</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;IV</td><td rowspan="1" colspan="1" align="center">1.02</td><td rowspan="1" colspan="1" align="center">0.54</td></tr><tr><td rowspan="1" colspan="1" align="left">ER status (%)</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;Positive</td><td rowspan="1" colspan="1" align="center">63.71</td><td rowspan="1" colspan="1" align="center">64.34</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;Negative</td><td rowspan="1" colspan="1" align="center">36.29</td><td rowspan="1" colspan="1" align="center">35.66</td></tr><tr><td rowspan="1" colspan="1" align="left">PR status(%)</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;Positive</td><td rowspan="1" colspan="1" align="center">63.24</td><td rowspan="1" colspan="1" align="center">58.03</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;Negative</td><td rowspan="1" colspan="1" align="center">36.76</td><td rowspan="1" colspan="1" align="center">41.97</td></tr><tr><td rowspan="1" colspan="1" align="left">Chemotherapy (%)</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;Yes</td><td rowspan="1" colspan="1" align="center">94.2</td><td rowspan="1" colspan="1" align="center">91.69</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;No</td><td rowspan="1" colspan="1" align="center">5.8</td><td rowspan="1" colspan="1" align="center">8.31</td></tr><tr><td rowspan="1" colspan="1" align="left">Radiotherapy (%)</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;Yes</td><td rowspan="1" colspan="1" align="center">36.58</td><td rowspan="1" colspan="1" align="center">32.23</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;No</td><td rowspan="1" colspan="1" align="center">63.42</td><td rowspan="1" colspan="1" align="center">67.77</td></tr><tr><td rowspan="1" colspan="1" align="left">Tamoxifen use (%)</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;Yes</td><td rowspan="1" colspan="1" align="center">67.09</td><td rowspan="1" colspan="1" align="center">51.27</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;No</td><td rowspan="1" colspan="1" align="center">32.91</td><td rowspan="1" colspan="1" align="center">48.73</td></tr><tr><td rowspan="1" colspan="1" align="left">Mastectomy (%)</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;Yes</td><td rowspan="1" colspan="1" align="center">99.9</td><td rowspan="1" colspan="1" align="center">99.73</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;No</td><td rowspan="1" colspan="1" align="center">0.1</td><td rowspan="1" colspan="1" align="center">0.27</td></tr><tr><td rowspan="1" colspan="1" align="left">5-year survival rate (%)</td><td rowspan="1" colspan="1" align="center">85.85</td><td rowspan="1" colspan="1" align="center">89.12</td></tr></tbody></table></div><div id="largeobj_idm140146739154576" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3294129/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><sup>a</sup>Patients with missing data were excluded.</div></div></div><p id="P11">Of the top 50 SNPs chosen for replication, 49 SNPs were successfully genotyped. Associations for all SNPs with breast cancer outcomes and <em>P</em>-values for HWE tests are presented in <a href="#SD2" rid="SD2" class=" supplementary-material">Supplementary Table S1</a>. A nominally statistically significant (<em>P</em>≤0.05) or marginally significant (<em>P</em>&lt;0.06) association with total mortality was observed for four SNPs: rs3784099, rs9934948, rs729438, and rs1769441, and the directions of the associations were consistent in both the discovery and replication stages (<a href="#SD2" rid="SD2" class=" supplementary-material">Supplementary Table 1</a>). For two SNPs, rs3784099 on chromosome 14 and rs9934948 on chromosome 16, the P-value for the combined analysis reached 1.17×10<sup>−7</sup> and 5.75×10<sup>−6</sup>, respectively (<a href="/pmc/articles/PMC3294129/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). SNP rs3784099 was associated with total mortality with a per-allele HR of 1.79 (95% confidence interval [CI]=1.46–2.19, <em>P<sub>trend</sub></em>=1.44×10<sup>−8</sup>) in the discovery stage, 1.22 (95%CI=0.99–1.52, <em>P<sub>trend</sub></em>=0.06) in the replication stage, and 1.49 (95%CI=1.28–1.72, <em>P<sub>trend</sub></em>=1.17×10<sup>−7</sup>) for all samples combined. In the recurrence analyses, the P<sub>trend</sub> for rs3784099 was of marginal statistical significance in the replication stage (<em>P</em>=0.07), and the direction of the association was consistent with the discovery stage. In the combined analysis, the per-allele HR for recurrence for rs3784099 was 1.43 (95%CI=1.25–1.64, <em>P<sub>trend</sub></em>=2.83×10<sup>−7</sup>). SNP rs9934948 showed a statistically significant association with total mortality (<em>P</em>=0.03) but was not significantly associated with recurrence (P= 0.32) in the replication stage. In combined analyses, per-allele HRs were 1.29 (95%CI=1.16–1.44, <em>P<sub>trend</sub></em>=5.75×10<sup>−6</sup>) for total mortality and 1.19 (95%CI=1.08–1.31, <em>P<sub>trend</sub></em>=7.32×10<sup>−4</sup>) for recurrence. Regional association plots for these 2 SNPs are presented in <a href="/pmc/articles/PMC3294129/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figures 1</span></a> and <a href="/pmc/articles/PMC3294129/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -1.5em;">and2.</span></span><span>2</span></a>. The associations of these two SNPs with total mortality and recurrence did not vary by ER or menopausal status (<a href="/pmc/articles/PMC3294129/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>). The vast majority of deaths among study participants were due to breast cancer (88%). In analyses of breast cancer-specific mortality, associations similar to those for total mortality were observed (HR=1.45, 95%CI=1.24–1.70, <em>P<sub>trend</sub></em>=3.8×10<sup>−6</sup> for rs3784099 and HR= 1.27, 95% CI=1.13–1.43, <em>P<sub>trend</sub></em>=6.0×10<sup>−5</sup> for rs9934948), although the P-values were increased due to decreased number of events (data not shown in tables).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3294129/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140146739893120" class="figure"><a href="/pmc/articles/PMC3294129/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3294129_nihms349335f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms349335f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3294129/bin/nihms349335f1.jpg"></a></div><div id="largeobj_idm140146739893120" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3294129/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3294129/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="P44">Regional association plots for total mortality in association with rs3784099 (panel A) and rs9934948 (panel B). Regional association plots for total mortality in association with rs3784099 (panel A) and rs9934948 (panel B). Chromosomal position is given on the X axis and the association P-values (−log10 P) on the Y axis. Referent SNPs are identified with purple diamonds and pairwise linkage disequilibrium with adjacent SNPs as measured by r<sup>2</sup> values (according to the HapMap 1000 Genomes June 2010 CHB+JPT data) is indicated with the color of each circle. Refseq genes are shown beneath each plot.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3294129/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140146739157568" class="figure"><a href="/pmc/articles/PMC3294129/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3294129_nihms349335f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms349335f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3294129/bin/nihms349335f2.jpg"></a></div><div id="largeobj_idm140146739157568" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3294129/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3294129/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="P45">Regional association plots for recurrence/breast cancer-specific mortality in association with rs3784099 (panel A) and rs9934948 (panel B). Regional association plots for recurrence/breast cancer-specific mortality in association with rs3784099 (panel A) and rs9934948 (panel B). Chromosomal position is given on the X axis and the association P-values (−log10 P) on the Y axis. Referent SNPs are identified with purple diamonds and pairwise linkage disequilibrium with adjacent SNPs as measured by r<sup>2</sup> values (according to the HapMap 1000 Genomes June 2010 CHB+JPT data) is indicated with the color of each circle. Refseq genes are shown beneath each plot.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="P48">Associations of breast cancer outcomes with the top two SNPs <sup>a</sup></p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140146813013648" class="xtable"><table frame="hsides" rules="none" class="rendered small default_table"><thead><tr><th colspan="2" rowspan="1" valign="bottom" align="left">SNP<hr></th><th rowspan="1" colspan="1" align="center">No. of<br>Events</th><th rowspan="1" colspan="1" align="center">All<br>participants</th><th rowspan="1" colspan="1" align="center">HR (95% CI)<br>(per allele)</th><th rowspan="1" colspan="1" align="center">HR (95% CI)<br>(heterozygous)</th><th rowspan="1" colspan="1" align="center">HR (95% CI)<br>(homozygous)</th><th rowspan="1" colspan="1" valign="top" align="center">P <sub>trend</sub></th></tr><tr><th rowspan="1" colspan="1" align="left"></th><th rowspan="1" colspan="1" align="left">stage</th><th rowspan="1" colspan="1" align="center"></th><th rowspan="1" colspan="1" align="center"></th><th rowspan="1" colspan="1" align="center"></th><th rowspan="1" colspan="1" align="center"></th><th rowspan="1" colspan="1" align="center"></th><th rowspan="1" colspan="1" align="center"></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="left">rs3784099</td><td rowspan="1" colspan="1" align="left">(<strong>A/G, 0.13</strong>) <sup>b</sup></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"><strong>Total Mortality</strong></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left">Discovery</td><td rowspan="1" colspan="1" align="center">276</td><td rowspan="1" colspan="1" align="center">1436</td><td rowspan="1" colspan="1" align="center">1.79 ( 1.46 – 2.19 )</td><td rowspan="1" colspan="1" align="center">1.77 ( 1.37 – 2.28 )</td><td rowspan="1" colspan="1" align="center">3.31 ( 1.92 – 5.71 )</td><td rowspan="1" colspan="1" align="center">1.44E-08</td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left">Replication</td><td rowspan="1" colspan="1" align="center">338</td><td rowspan="1" colspan="1" align="center">3809</td><td rowspan="1" colspan="1" align="center">1.22 ( 0.99 – 1.52 )</td><td rowspan="1" colspan="1" align="center">1.14 ( 0.89 – 1.47 )</td><td rowspan="1" colspan="1" align="center">2.05 ( 1.05 – 4.00 )</td><td rowspan="1" colspan="1" align="center">6.44E-02</td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left">Combined</td><td rowspan="1" colspan="1" align="center">614</td><td rowspan="1" colspan="1" align="center">5245</td><td rowspan="1" colspan="1" align="center">1.49 ( 1.28 – 1.72 )</td><td rowspan="1" colspan="1" align="center">1.41 ( 1.18 – 1.68 )</td><td rowspan="1" colspan="1" align="center">2.64 ( 1.74 – 4.03 )</td><td rowspan="1" colspan="1" align="center">1.17E-07</td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"><strong>Recurrence</strong></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left">Discovery</td><td rowspan="1" colspan="1" align="center">343</td><td rowspan="1" colspan="1" align="center">1405</td><td rowspan="1" colspan="1" align="center">1.73 ( 1.43 – 2.09 )</td><td rowspan="1" colspan="1" align="center">1.69 ( 1.34 – 2.13 )</td><td rowspan="1" colspan="1" align="center">3.20 ( 1.86 – 5.50 )</td><td rowspan="1" colspan="1" align="center">1.75E-08</td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left">Replication</td><td rowspan="1" colspan="1" align="center">456</td><td rowspan="1" colspan="1" align="center">3809</td><td rowspan="1" colspan="1" align="center">1.20 ( 0.99 – 1.46 )</td><td rowspan="1" colspan="1" align="center">1.06 ( 0.84 – 1.34 )</td><td rowspan="1" colspan="1" align="center">2.32 ( 1.33 – 4.05 )</td><td rowspan="1" colspan="1" align="center">7.05E-02</td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left">Combined</td><td rowspan="1" colspan="1" align="center">799</td><td rowspan="1" colspan="1" align="center">5214</td><td rowspan="1" colspan="1" align="center">1.43 ( 1.25 – 1.64 )</td><td rowspan="1" colspan="1" align="center">1.32 ( 1.12 – 1.55 )</td><td rowspan="1" colspan="1" align="center">2.69 ( 1.82 – 3.96 )</td><td rowspan="1" colspan="1" align="center">2.83E-07</td></tr><tr><td rowspan="1" colspan="1" align="left">rs9934948</td><td rowspan="1" colspan="1" align="left">(<strong>C/T, 0.46</strong>) <sup>b</sup></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"><strong>Total Mortality</strong></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left">Discovery</td><td rowspan="1" colspan="1" align="center">276</td><td rowspan="1" colspan="1" align="center">1436</td><td rowspan="1" colspan="1" align="center">1.45 ( 1.23 – 1.71 )</td><td rowspan="1" colspan="1" align="center">1.37 ( 1.01 – 1.85 )</td><td rowspan="1" colspan="1" align="center">2.09 ( 1.51 – 2.90 )</td><td rowspan="1" colspan="1" align="center">9.71E-06</td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left">Replication</td><td rowspan="1" colspan="1" align="center">338</td><td rowspan="1" colspan="1" align="center">3807</td><td rowspan="1" colspan="1" align="center">1.18 ( 1.02 – 1.37 )</td><td rowspan="1" colspan="1" align="center">1.29 ( 0.99 – 1.68 )</td><td rowspan="1" colspan="1" align="center">1.40 ( 1.03 – 1.90 )</td><td rowspan="1" colspan="1" align="center">2.76E-02</td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left">Combined</td><td rowspan="1" colspan="1" align="center">614</td><td rowspan="1" colspan="1" align="center">5243</td><td rowspan="1" colspan="1" align="center">1.29 ( 1.16 – 1.44 )</td><td rowspan="1" colspan="1" align="center">1.31 ( 1.08 – 1.60 )</td><td rowspan="1" colspan="1" align="center">1.67 ( 1.34 – 2.09 )</td><td rowspan="1" colspan="1" align="center">5.75E-06</td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"><strong>Recurrence</strong></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left">Discovery</td><td rowspan="1" colspan="1" align="center">343</td><td rowspan="1" colspan="1" align="center">1405</td><td rowspan="1" colspan="1" align="center">1.37 ( 1.18 – 1.59 )</td><td rowspan="1" colspan="1" align="center">1.26 ( 0.96 – 1.65 )</td><td rowspan="1" colspan="1" align="center">1.86 ( 1.38 – 2.49 )</td><td rowspan="1" colspan="1" align="center">4.20E-05</td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left">Replication</td><td rowspan="1" colspan="1" align="center">457</td><td rowspan="1" colspan="1" align="center">3807</td><td rowspan="1" colspan="1" align="center">1.07 ( 0.93 – 1.23 )</td><td rowspan="1" colspan="1" align="center">1.11 ( 0.88 – 1.40 )</td><td rowspan="1" colspan="1" align="center">1.14 ( 0.87 – 1.50 )</td><td rowspan="1" colspan="1" align="center">3.24E-01</td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left">Combined</td><td rowspan="1" colspan="1" align="center">800</td><td rowspan="1" colspan="1" align="center">5212</td><td rowspan="1" colspan="1" align="center">1.19 ( 1.08 – 1.31 )</td><td rowspan="1" colspan="1" align="center">1.16 ( 0.98 – 1.39 )</td><td rowspan="1" colspan="1" align="center">1.41 ( 1.16 – 1.73 )</td><td rowspan="1" colspan="1" align="center">7.32E-04</td></tr></tbody></table></div><div id="largeobj_idm140146813013648" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3294129/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN2"><sup>a</sup>Adjusted for age at diagnosis.</div><div id="TFN3"><sup>b</sup>Effect allele/reference allele, effect allele frequency, all SNPs were coded on the forward strand.</div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="P51">Associations of breast cancer outcomes with the two newly identified SNPs and one GWAS-identified SNP by tumor and participant characteristics <sup>a</sup></p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140146741546112" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="left">SNP <sup>b</sup></th><th rowspan="1" colspan="1" align="center">No. of<br>Events</th><th rowspan="1" colspan="1" align="center">All<br>participants</th><th rowspan="1" colspan="1" align="center">HR (95% CI)<br>per allele</th><th rowspan="1" colspan="1" align="center">HR (95% CI)<br>heterozygous</th><th rowspan="1" colspan="1" align="center">HR (95% CI)<br>homozygous</th><th rowspan="1" colspan="1" valign="top" align="left">P <sub>trend</sub></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td colspan="2" rowspan="1" align="center"><strong>Total Mortality</strong></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td colspan="7" rowspan="1" valign="bottom" align="left"><hr></td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"><em><strong>ER-positive breast cancer</strong></em></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">rs3784099 (A/G, 0.13)</td><td rowspan="1" colspan="1" align="center">282</td><td rowspan="1" colspan="1" align="center">3097</td><td rowspan="1" colspan="1" align="center">1.71 ( 1.39 – 2.11 )</td><td rowspan="1" colspan="1" align="center">1.67 ( 1.29 – 2.15 )</td><td rowspan="1" colspan="1" align="center">3.19 ( 1.73 – 5.86 )</td><td rowspan="1" colspan="1" align="left">5.11 × 10<sup>−07</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">rs9934948 (C/T, 0.46)</td><td rowspan="1" colspan="1" align="center">283</td><td rowspan="1" colspan="1" align="center">3100</td><td rowspan="1" colspan="1" align="center">1.23 ( 1.05 – 1.45 )</td><td rowspan="1" colspan="1" align="center">1.24 ( 0.93 – 1.66 )</td><td rowspan="1" colspan="1" align="center">1.52 ( 1.10 – 2.10 )</td><td rowspan="1" colspan="1" align="left">0.012</td></tr><tr><td rowspan="1" colspan="1" align="left">rs4778137 (C/G, 0.19)</td><td rowspan="1" colspan="1" align="center">150</td><td rowspan="1" colspan="1" align="center">1252</td><td rowspan="1" colspan="1" align="center">1.27 ( 0.96 – 1.68 )</td><td rowspan="1" colspan="1" align="center">1.10 ( 0.78 – 1.56 )</td><td rowspan="1" colspan="1" align="center">2.29 ( 1.16 – 4.55 )</td><td rowspan="1" colspan="1" align="left">0.091</td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"><em><strong>ER-negative breast cancer</strong></em></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">rs3784099 (A/G, 0.13)</td><td rowspan="1" colspan="1" align="center">226</td><td rowspan="1" colspan="1" align="center">1726</td><td rowspan="1" colspan="1" align="center">1.13 ( 0.87 – 1.47 )</td><td rowspan="1" colspan="1" align="center">0.94 ( 0.68 – 1.29 )</td><td rowspan="1" colspan="1" align="center">2.41 ( 1.23 – 4.72 )</td><td rowspan="1" colspan="1" align="left">0.354</td></tr><tr><td rowspan="1" colspan="1" align="left">rs9934948 (C/T, 0.46)</td><td rowspan="1" colspan="1" align="center">225</td><td rowspan="1" colspan="1" align="center">1721</td><td rowspan="1" colspan="1" align="center">1.26 ( 1.05 – 1.52 )</td><td rowspan="1" colspan="1" align="center">1.29 ( 0.93 – 1.79 )</td><td rowspan="1" colspan="1" align="center">1.60 ( 1.10 – 2.33 )</td><td rowspan="1" colspan="1" align="left">0.013</td></tr><tr><td rowspan="1" colspan="1" align="left">rs4778137 (C/G, 0.19)</td><td rowspan="1" colspan="1" align="center">90</td><td rowspan="1" colspan="1" align="center">691</td><td rowspan="1" colspan="1" align="center">0.95 ( 0.64 – 1.41 )</td><td rowspan="1" colspan="1" align="center">0.86 ( 0.54 – 1.36 )</td><td rowspan="1" colspan="1" align="center">1.37 ( 0.43 – 4.38 )</td><td rowspan="1" colspan="1" align="left">0.792</td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"><em><strong>Pre-menopausal women</strong></em></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">rs3784099 (A/G, 0.13)</td><td rowspan="1" colspan="1" align="center">305</td><td rowspan="1" colspan="1" align="center">2725</td><td rowspan="1" colspan="1" align="center">1.52 ( 1.25 – 1.86 )</td><td rowspan="1" colspan="1" align="center">1.47 ( 1.14 – 1.88 )</td><td rowspan="1" colspan="1" align="center">2.58 ( 1.47 – 4.52 )</td><td rowspan="1" colspan="1" align="left">4.16 × 10<sup>−05</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">rs9934948 (C/T, 0.46)</td><td rowspan="1" colspan="1" align="center">305</td><td rowspan="1" colspan="1" align="center">2720</td><td rowspan="1" colspan="1" align="center">1.29 ( 1.10 – 1.51 )</td><td rowspan="1" colspan="1" align="center">1.10 ( 0.83 – 1.45 )</td><td rowspan="1" colspan="1" align="center">1.64 ( 1.21 – 2.22 )</td><td rowspan="1" colspan="1" align="left">0.002</td></tr><tr><td rowspan="1" colspan="1" align="left">rs4778137 (C/G, 0.19)</td><td rowspan="1" colspan="1" align="center">197</td><td rowspan="1" colspan="1" align="center">1354</td><td rowspan="1" colspan="1" align="center">1.29 ( 1.02 – 1.64 )</td><td rowspan="1" colspan="1" align="center">1.11 ( 0.81 – 1.50 )</td><td rowspan="1" colspan="1" align="center">2.34 ( 1.32 – 4.15 )</td><td rowspan="1" colspan="1" align="left">0.037</td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"><em><strong>Post-menopausal women</strong></em></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">rs3784099 (A/G, 0.13)</td><td rowspan="1" colspan="1" align="center">309</td><td rowspan="1" colspan="1" align="center">2520</td><td rowspan="1" colspan="1" align="center">1.45 ( 1.17 – 1.80 )</td><td rowspan="1" colspan="1" align="center">1.35 ( 1.05 – 1.74 )</td><td rowspan="1" colspan="1" align="center">2.83 ( 1.50 – 5.35 )</td><td rowspan="1" colspan="1" align="left">6.23 × 10<sup>−04</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">rs9934948 (C/T, 0.46)</td><td rowspan="1" colspan="1" align="center">309</td><td rowspan="1" colspan="1" align="center">2523</td><td rowspan="1" colspan="1" align="center">1.30 ( 1.11 – 1.52 )</td><td rowspan="1" colspan="1" align="center">1.58 ( 1.19 – 2.09 )</td><td rowspan="1" colspan="1" align="center">1.71 ( 1.23 – 2.37 )</td><td rowspan="1" colspan="1" align="left">0.001</td></tr><tr><td rowspan="1" colspan="1" align="left">rs4778137 (C/G, 0.19)</td><td rowspan="1" colspan="1" align="center">134</td><td rowspan="1" colspan="1" align="center">955</td><td rowspan="1" colspan="1" align="center">1.18 ( 0.87 – 1.60 )</td><td rowspan="1" colspan="1" align="center">1.29 ( 0.91 – 1.83 )</td><td rowspan="1" colspan="1" align="center">0.93 ( 0.29 – 2.93 )</td><td rowspan="1" colspan="1" align="left">0.278</td></tr><tr><td colspan="7" rowspan="1" valign="bottom" align="left"><hr></td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td colspan="2" rowspan="1" align="center"><strong>Recurrence</strong></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td colspan="7" rowspan="1" valign="bottom" align="left"><hr></td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"><em><strong>ER-positive breast cancer</strong></em></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">rs3784099 (A/G, 0.13)</td><td rowspan="1" colspan="1" align="center">383</td><td rowspan="1" colspan="1" align="center">3084</td><td rowspan="1" colspan="1" align="center">1.50 ( 1.23 – 1.82 )</td><td rowspan="1" colspan="1" align="center">1.38 ( 1.09 – 1.75 )</td><td rowspan="1" colspan="1" align="center">2.95 ( 1.69 – 5.16 )</td><td rowspan="1" colspan="1" align="left">5.47 × 10<sup>−05</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">rs9934948 (C/T, 0.46)</td><td rowspan="1" colspan="1" align="center">384</td><td rowspan="1" colspan="1" align="center">3087</td><td rowspan="1" colspan="1" align="center">1.17 ( 1.02 – 1.36 )</td><td rowspan="1" colspan="1" align="center">1.18 ( 0.91 – 1.51 )</td><td rowspan="1" colspan="1" align="center">1.38 ( 1.03 – 1.84 )</td><td rowspan="1" colspan="1" align="left">0.029</td></tr><tr><td rowspan="1" colspan="1" align="left">rs4778137 (C/G, 0.19)</td><td rowspan="1" colspan="1" align="center">213</td><td rowspan="1" colspan="1" align="center">1239</td><td rowspan="1" colspan="1" align="center">1.15 ( 0.91 – 1.47 )</td><td rowspan="1" colspan="1" align="center">1.09 ( 0.82 – 1.47 )</td><td rowspan="1" colspan="1" align="center">1.58 ( 0.80 – 3.10 )</td><td rowspan="1" colspan="1" align="left">0.246</td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"><em><strong>ER-negative breast cancer</strong></em></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">rs3784099 (A/G, 0.13)</td><td rowspan="1" colspan="1" align="center">298</td><td rowspan="1" colspan="1" align="center">1717</td><td rowspan="1" colspan="1" align="center">1.19 ( 0.94 – 1.50 )</td><td rowspan="1" colspan="1" align="center">0.95 ( 0.71 – 1.27 )</td><td rowspan="1" colspan="1" align="center">2.83 ( 1.58 – 5.07 )</td><td rowspan="1" colspan="1" align="left">0.153</td></tr><tr><td rowspan="1" colspan="1" align="left">rs9934948 (C/T, 0.46)</td><td rowspan="1" colspan="1" align="center">298</td><td rowspan="1" colspan="1" align="center">1712</td><td rowspan="1" colspan="1" align="center">1.11 ( 0.94 – 1.31 )</td><td rowspan="1" colspan="1" align="center">1.09 ( 0.82 – 1.46 )</td><td rowspan="1" colspan="1" align="center">1.23 ( 0.88 – 1.73 )</td><td rowspan="1" colspan="1" align="left">0.225</td></tr><tr><td rowspan="1" colspan="1" align="left">rs4778137 (C/G, 0.19)</td><td rowspan="1" colspan="1" align="center">121</td><td rowspan="1" colspan="1" align="center">682</td><td rowspan="1" colspan="1" align="center">0.90 ( 0.63 – 1.28 )</td><td rowspan="1" colspan="1" align="center">0.91 ( 0.62 – 1.35 )</td><td rowspan="1" colspan="1" align="center">0.73 ( 0.18 – 2.95 )</td><td rowspan="1" colspan="1" align="left">0.548</td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"><em><strong>Pre-menopausal women</strong></em></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">rs3784099 (A/G, 0.13)</td><td rowspan="1" colspan="1" align="center">420</td><td rowspan="1" colspan="1" align="center">2702</td><td rowspan="1" colspan="1" align="center">1.39 ( 1.16 – 1.68 )</td><td rowspan="1" colspan="1" align="center">1.32 ( 1.05 – 1.64 )</td><td rowspan="1" colspan="1" align="center">2.37 ( 1.38 – 4.05 )</td><td rowspan="1" colspan="1" align="left">4.48 × 10<sup>−04</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">rs9934948 (C/T, 0.46)</td><td rowspan="1" colspan="1" align="center">420</td><td rowspan="1" colspan="1" align="center">2697</td><td rowspan="1" colspan="1" align="center">1.21 ( 1.05 – 1.39 )</td><td rowspan="1" colspan="1" align="center">1.11 ( 0.87 – 1.41 )</td><td rowspan="1" colspan="1" align="center">1.45 ( 1.11 – 1.91 )</td><td rowspan="1" colspan="1" align="left">0.007</td></tr><tr><td rowspan="1" colspan="1" align="left">rs4778137 (C/G, 0.19)</td><td rowspan="1" colspan="1" align="center">262</td><td rowspan="1" colspan="1" align="center">1331</td><td rowspan="1" colspan="1" align="center">1.16 ( 0.94 – 1.44 )</td><td rowspan="1" colspan="1" align="center">1.05 ( 0.80 – 1.38 )</td><td rowspan="1" colspan="1" align="center">1.76 ( 1.00 – 3.10 )</td><td rowspan="1" colspan="1" align="left">0.175</td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"><em><strong>Post-menopausal women</strong></em></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">rs3784099 (A/G, 0.13)</td><td rowspan="1" colspan="1" align="center">379</td><td rowspan="1" colspan="1" align="center">2512</td><td rowspan="1" colspan="1" align="center">1.48 ( 1.21 – 1.81 )</td><td rowspan="1" colspan="1" align="center">1.32 ( 1.04 – 1.68 )</td><td rowspan="1" colspan="1" align="center">3.26 ( 1.86 – 5.70 )</td><td rowspan="1" colspan="1" align="left">1.14 × 10<sup>−04</sup>
</td></tr><tr><td rowspan="1" colspan="1" align="left">rs9934948 (C/T, 0.46)</td><td rowspan="1" colspan="1" align="center">380</td><td rowspan="1" colspan="1" align="center">2515</td><td rowspan="1" colspan="1" align="center">1.17 ( 1.01 – 1.36 )</td><td rowspan="1" colspan="1" align="center">1.24 ( 0.96 – 1.60 )</td><td rowspan="1" colspan="1" align="center">1.37 ( 1.02 – 1.84 )</td><td rowspan="1" colspan="1" align="left">0.035</td></tr><tr><td rowspan="1" colspan="1" align="left">rs4778137 (C/G, 0.19)</td><td rowspan="1" colspan="1" align="center">175</td><td rowspan="1" colspan="1" align="center">947</td><td rowspan="1" colspan="1" align="center">1.03 ( 0.78 – 1.35 )</td><td rowspan="1" colspan="1" align="center">1.16 ( 0.85 – 1.57 )</td><td rowspan="1" colspan="1" align="center">0.45 ( 0.11 – 1.83 )</td><td rowspan="1" colspan="1" align="left">0.846</td></tr></tbody></table></div><div id="largeobj_idm140146741546112" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3294129/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN4"><sup>a</sup>Combined data from all study stages; adjusted for age at diagnosis</div><div id="TFN5"><sup>b</sup>Effect allele/reference allele, effect allele frequency; all SNPs were coded on the forward strand.</div></div></div><p id="P12" class="p p-last">SNP rs9934948 was associated with total mortality in European-ancestry Americans and the direction of association was the same as that observed in the Shanghai studies (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table S2</a>). The age-adjusted HRs were 3.27 (95%CI=0.75–14.19) for the <em>CT</em> genotype and 4.70 (95%CI=1.11–19.97) for the <em>CC</em> genotype compared with the <em>TT</em> genotype (<em>P<sub>trend</sub></em>=0.006). Meta-analyses combining Shanghai samples and CGEMS data showed a combined P-value of 1.39×10<sup>−7</sup>. Data on recurrence were not available for CGEMS participants.</p></div><div id="S7" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S7title">DISCUSSION</h2><p id="P13" class="p p-first">In this two-stage GWAS of breast cancer survival conducted among Chinese women, we found strong evidence for an association of SNP rs3784099 with total mortality and with recurrence and breast cancer-specific mortality. This SNP is located on chromosome 14 in intron 7 of the <em>RAD51L1</em> gene, an established cancer susceptibility gene (<a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879832">27</a>). The <em>RAD51L1</em> gene encodes a protein that is part of the RAD51 family, which is essential for DNA repair by homologous recombination. Over-expression of this gene has been shown to cause cell cycle delay and apoptosis (<a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879828">27</a>, <a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879818">28</a>). The <em>RAD51L1</em> gene is not ubiquitously expressed, but it is significantly expressed in breast cancer-derived MCF7 cells (<a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879836">29</a>). A recent GWAS identified a SNP in this gene, rs999737, to be associated with breast cancer risk (<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879834">16</a>). SNP rs999737, however, was not related to breast cancer survival in our study (data not presented), nor is it in LD with SNP rs3784099 (r<sup>2</sup>=0 in Asians and r<sup>2</sup>=0.032 in Europeans based on HapMap data).</p><p id="P14">SNP rs3784099 is also associated with differential expression of two other genes involved in cancer, <em>SNCG</em> and <em>CTF1</em>, according to the SCAN database (<a href="#R30" rid="R30" class=" bibr popnode">30</a>), which uses HapMap human lymphoblastoid cell lines to identify expression quantitative trait loci (eQTL) (<a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879794">31</a>). Both genes yielded a <em>P</em> value of 0.0001 in cell lines of European ancestry (CEU), though the specific allele of rs3784099 responsible for increased/decreased expression is not apparent in this resource. The <em>SNCG</em> gene encodes synuclein gamma, also known as breast cancer-specific protein 1 (<a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879837">32</a>). Up-regulation of the <em>SNCG</em> gene has been shown to enhance cancer cell motility and contributes to cancer cell survival (<a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879824">32</a>). There are indications that the <em>SNCG</em> gene may be involved in late-stage breast and ovarian cancer metastasis by enhancing cell motility through activation of RHO-family small GTPases and extracellular signal-regulated kinases (ERK) (<a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879830">32</a>, <a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879815">33</a>). Over-expression of the <em>SNCG</em> gene is a marker for breast cancer progression and a potential target for breast cancer treatment (<a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879803">32</a>, <a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879829">34</a>). The <em>CTF1</em> gene is a transcription factor that can delimit chromatin boundaries and thereby block the propagation of silent chromatin (<a href="#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879840">35</a>). These data provide additional support for the association between rs3784099 and breast cancer outcomes observed in our study.</p><p id="P15">SNP rs9934948 resides on chromosome 16, in the middle of a gene desert with its nearest neighboring genes, <em>ZFHX3</em> and <em>PSMD7</em>, 346kb and 891kb away, respectively. <em>ZFHX3</em> is one of the homeobox genes that are often located in gene deserts. <em>PSMD7</em> is a proteasome component (<a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879810">36</a>) and has been previously shown to be one of the genes most impacted by siRNA knock down of the ER in MCF cells (<a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879838">37</a>). Proteasome activity is increased in tumor cells, resulting in increased turnover rates for signaling molecules that are involved in the regulation of cell growth and apoptosis (<a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879811">38</a>). These biological links and the strong association of this SNP with total mortality observed among breast cancer survivors of European ancestry in CGEMS data support a possible role for rs9934948 in breast cancer prognosis.</p><p id="P16">To date, only one GWAS-identified SNP, rs4778137, has been associated with breast cancer survival, although the association for this SNP did not reach the conventional genome-wide significance level of 5×10<sup>−8</sup> (only 5×10<sup>−4</sup>) (<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879790">19</a>). We evaluated this SNP using the scanned data from our discovery stage and found that rs4778137 was significantly associated with total mortality (per allele HR=1.25, 95%CI=1.03–1.51, P<sub>trend</sub>= 0.02; data not shown in tables). The association was observed predominantly among pre-menopausal women (per allele HR=1.29, 95%CI=1.02–1.64) and women with ER-positive breast cancer (per allele HR=1.27, 95%CI=0.96–1.68). Thus, our results provide some support for the association identified by the previous GWAS conducted among women of European ancestry.</p><p id="P17">Given the difference in genetic architecture across ethnic groups, disease-associated SNPs identified in one population are often not replicated directly in another population. In a recent study conducted among approximately 6,000 female Chinese cancer patients and controls in Shanghai, only 8 of the 12 breast cancer risk SNPs identified in women of European ancestry could be directly replicated (<a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_252879805">39</a>). Therefore, it is not surprising that the top SNP identified by our study, rs3784099, was not directly replicated in the CGEMS data. Differences in study eligibility could also have contributed to the lack of replication. For example, CGEMS only included post-menopausal women, while the SBCS over-sampled younger breast cancer patients. However, we did not find the association of rs3784099 to be modified by menopausal status. On the other hand, replication of an association in other ethnic groups, as is the case with rs9934948, provides additional evidence for a true association.</p><p id="P18" class="p p-last">In summary, we found that genetic variants in the <em>RAD51L1</em> gene and chromosome 16 were associated with survival among breast cancer patients. Additional research on the genetic regions and genes identified by our study would lead to a better understanding of the biological mechanisms responsible for breast cancer progression and survival.</p></div><div id="SM" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="SMtitle">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>1</h4><div class="sup-box half_rhythm" id="N0x16013fc0N0x1716f960"><a href="/pmc/articles/PMC3294129/bin/NIHMS349335-supplement-1.docx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(25K, docx)</sup></div></div><div class="sec suppmat" id="SD2"><h4>2</h4><div class="sup-box half_rhythm" id="N0x16013fc0N0x1716fa20"><a href="/pmc/articles/PMC3294129/bin/NIHMS349335-supplement-2.docx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(94K, docx)</sup></div></div></div><div id="S8" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S8title">Acknowledgement</h2><div class="sec"><p id="P19"><strong>Financial Support:</strong> This work was supported by the US National Institutes of Health/National Cancer Institute (grant numbers: R01CA118229 to X.O.S. and R01CA124558, R01CA064277, and R01CA090899 to W.Z.), as well as the US Department of Defense (DOD) Breast Cancer Research Program (Idea Awards <a id="__tag_811194384" class="tag_hotlink" href="/nuccore/BC011118" ref="/nuccore/BC011118"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"BC011118","term_id":"15029793","term_text":"BC011118"}}</span>BC011118</a> to X.O.S. and <a id="__tag_811194385" class="tag_hotlink" href="/nuccore/BC050791" ref="/nuccore/BC050791"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"BC050791","term_id":"29747970","term_text":"BC050791"}}</span>BC050791</a> to Q.C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or Department of Defense. Sample preparation and discovery stage genotyping were conducted at the Survey and Biospecimen and Microarray Shared Resources, which are supported in part by the Vanderbilt-Ingram Cancer Center (P30 CA68485).</p><p id="P20">The authors wish to thank study participants and research staff for their contributions and commitment to this project, Ms. Regina Courtney for DNA preparation, and Ms. Bethanie Rammer for editorial support in the preparation of this manuscript.</p></div></div><div id="idm140146780213120" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140146780213120title">Abbreviations</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td>CGEMS</td><td>Cancer Genetic Markers of Susceptibility</td></tr><tr><td>CI</td><td>confidence interval</td></tr><tr><td>eQTL</td><td>expression quantitative trait loci</td></tr><tr><td>ER</td><td>estrogen receptor</td></tr><tr><td>GRS</td><td>genetic risk score</td></tr><tr><td>GWAS</td><td>genome-wide association study</td></tr><tr><td>HR</td><td>hazard ratio</td></tr><tr><td>HWE</td><td>Hardy-Weinberg equilibrium</td></tr><tr><td>LD</td><td>linkage disequilibrium</td></tr><tr><td>MAF</td><td>minor allele frequency</td></tr><tr><td>MDS</td><td>multidimensional scaling</td></tr><tr><td>NHS</td><td>Nurses’ Health Study</td></tr><tr><td>PCR</td><td>polymerase chain reaction</td></tr><tr><td>PR</td><td>progesterone receptor</td></tr><tr><td>QC</td><td>quality control</td></tr><tr><td>SBCS</td><td>Shanghai Breast Cancer Study</td></tr><tr><td>SBCSS</td><td>Shanghai Breast Cancer Survival Study</td></tr><tr><td>SNP</td><td>single nucleotide polymorphism</td></tr><tr><td>TNM</td><td>tumor-node-metastasis</td></tr><tr><td>UTR</td><td>untranslated region</td></tr></tbody></table></div></div></div><div id="idm140146778031536" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140146778031536title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN1"> </p><p id="P21" class="p p-first-last"><strong>Conflicts of Interest:</strong> The authors have no conflicts of interest to declare.</p><p></p><div><p id="P22" class="p p-first-last"><strong>Author Contributions:</strong> Xiao Ou Shu conceived, designed, and implemented the study; analyzed and interpreted the data; drafted the manuscript.; and obtained funding for the study. Jirong Long analyzed data and contributed to writing the manuscript. Wei Lu designed and implemented the study. Chun Li contributed to data analysis and data interpretation. Wendy Y. Chen contributed to the data analysis and data interpretation and provided critical review of the manuscript. Ryan Delahanty contributed to the writing of the manuscript. Jiarong Cheng contributed to study implementation. Hui Cai contributed to the data analysis. Ying Zheng contributed to the study design and implementation. Jiajun Shi performed the genotyping. Kai Gu contributed to study implementation. Wen-Jing Wang contributed to study implementation. Peter Kraft contributed to data interpretation and provided critical review of the paper. Yu-Tang Gao designed and implemented the study. Qiuyin Cai contributed to the design and implementation of the study, interpretation of the data, and funding of the study. Wei Zheng conceived, designed, and implemented the study; contributed to interpretation of the data; provided critical review of the paper; and contributed to the funding of the study.</p></div><p class="fn sec" id="FN3"></p><p id="P23" class="p p-first-last">Xiao Ou Shu confirms that she had full access to all of the study data and bears final responsibility for the decision to submit the paper.</p><p></p></div></div><div id="idm140146776736112" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140146776736112title">Reference List</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Shu XO, Gao YT, Cai Q, Pierce L, Cai H, Ruan ZX, et al.  Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study. <span><span class="ref-journal">Cancer Res. </span>2004;<span class="ref-vol">64</span>:836–839.</span> [<a href="/pubmed/14871809" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Genetic+polymorphisms+in+the+TGF-beta+1+gene+and+breast+cancer+survival:+a+report+from+the+Shanghai+Breast+Cancer+Study&amp;author=XO+Shu&amp;author=YT+Gao&amp;author=Q+Cai&amp;author=L+Pierce&amp;author=H+Cai&amp;volume=64&amp;publication_year=2004&amp;pages=836-839&amp;pmid=14871809&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Lu H, Shu XO, Cui Y, Kataoka N, Wen W, Cai Q, et al.  Association of genetic polymorphisms in the VEGF gene with breast cancer survival. <span><span class="ref-journal">Cancer Res. </span>2005;<span class="ref-vol">65</span>:5015–5019.</span> [<a href="/pubmed/15958542" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Association+of+genetic+polymorphisms+in+the+VEGF+gene+with+breast+cancer+survival&amp;author=H+Lu&amp;author=XO+Shu&amp;author=Y+Cui&amp;author=N+Kataoka&amp;author=W+Wen&amp;volume=65&amp;publication_year=2005&amp;pages=5015-5019&amp;pmid=15958542&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Shu XO, Moore DB, Cai Q, Cheng J, Wen W, Pierce L, et al.  Association of cyclin D1 genotype with breast cancer risk and survival. <span><span class="ref-journal">Cancer Epidemiol Biomarkers Prev. </span>2005;<span class="ref-vol">14</span>:91–97.</span> [<a href="/pubmed/15668481" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Epidemiol+Biomarkers+Prev&amp;title=Association+of+cyclin+D1+genotype+with+breast+cancer+risk+and+survival&amp;author=XO+Shu&amp;author=DB+Moore&amp;author=Q+Cai&amp;author=J+Cheng&amp;author=W+Wen&amp;volume=14&amp;publication_year=2005&amp;pages=91-97&amp;pmid=15668481&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Zhang X, Shu XO, Cai Q, Ruan Z, Gao YT, Zheng W. Functional plasminogen activator inhibitor-1 gene variants and breast cancer survival. <span><span class="ref-journal">Clin Cancer Res. </span>2006;<span class="ref-vol">12</span>:6037–6042.</span> [<a href="/pubmed/17062678" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Functional+plasminogen+activator+inhibitor-1+gene+variants+and+breast+cancer+survival&amp;author=X+Zhang&amp;author=XO+Shu&amp;author=Q+Cai&amp;author=Z+Ruan&amp;author=YT+Gao&amp;volume=12&amp;publication_year=2006&amp;pages=6037-6042&amp;pmid=17062678&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Beeghly-Fadiel A, Shu XO, Long J, Li C, Cai Q, Cai H, et al.  Genetic polymorphisms in the MMP-7 gene and breast cancer survival. <span><span class="ref-journal">Int J Cancer. </span>2009;<span class="ref-vol">124</span>:208–214.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2597698/">PMC free article</a>]</span> [<a href="/pubmed/18798254" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer&amp;title=Genetic+polymorphisms+in+the+MMP-7+gene+and+breast+cancer+survival&amp;author=A+Beeghly-Fadiel&amp;author=XO+Shu&amp;author=J+Long&amp;author=C+Li&amp;author=Q+Cai&amp;volume=124&amp;publication_year=2009&amp;pages=208-214&amp;pmid=18798254&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Chappuis PO, Kapusta L, Begin LR, Wong N, Brunet JS, Narod SA, et al.  Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer. <span><span class="ref-journal">J Clin Oncol. </span>2000;<span class="ref-vol">18</span>:4045–4052.</span> [<a href="/pubmed/11118465" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Germline+BRCA1/2+mutations+and+p27(Kip1)+protein+levels+independently+predict+outcome+after+breast+cancer&amp;author=PO+Chappuis&amp;author=L+Kapusta&amp;author=LR+Begin&amp;author=N+Wong&amp;author=JS+Brunet&amp;volume=18&amp;publication_year=2000&amp;pages=4045-4052&amp;pmid=11118465&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Kriege M, Seynaeve C, Meijers-Heijboer H, Collee JM, Menke-Pluymers MB, Bartels CC, et al.  Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers. <span><span class="ref-journal">J Clin Oncol. </span>2009;<span class="ref-vol">27</span>:3764–3771.</span> [<a href="/pubmed/19564533" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Sensitivity+to+first-line+chemotherapy+for+metastatic+breast+cancer+in+BRCA1+and+BRCA2+mutation+carriers&amp;author=M+Kriege&amp;author=C+Seynaeve&amp;author=H+Meijers-Heijboer&amp;author=JM+Collee&amp;author=MB+Menke-Pluymers&amp;volume=27&amp;publication_year=2009&amp;pages=3764-3771&amp;pmid=19564533&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, et al.  p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer. <span><span class="ref-journal">Clin Cancer Res. </span>2005;<span class="ref-vol">11</span>:7328–7333.</span> [<a href="/pubmed/16243804" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=p53+Codon+72+polymorphism+predicts+the+pathologic+response+to+neoadjuvant+chemotherapy+in+patients+with+breast+cancer&amp;author=Y+Xu&amp;author=L+Yao&amp;author=T+Ouyang&amp;author=J+Li&amp;author=T+Wang&amp;volume=11&amp;publication_year=2005&amp;pages=7328-7333&amp;pmid=16243804&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Fagerholm R, Hofstetter B, Tommiska J, Aaltonen K, Vrtel R, Syrjakoski K, et al.  NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>:844–853.</span> [<a href="/pubmed/18511948" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=NAD(P)H:quinone+oxidoreductase+1+NQO1*2+genotype+(P187S)+is+a+strong+prognostic+and+predictive+factor+in+breast+cancer&amp;author=R+Fagerholm&amp;author=B+Hofstetter&amp;author=J+Tommiska&amp;author=K+Aaltonen&amp;author=R+Vrtel&amp;volume=40&amp;publication_year=2008&amp;pages=844-853&amp;pmid=18511948&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Hoskins JM, Carey LA, McLeod HL. CYP2D6 and tamoxifen: DNA matters in breast cancer. <span><span class="ref-journal">Nat Rev Cancer. </span>2009;<span class="ref-vol">9</span>:576–586.</span> [<a href="/pubmed/19629072" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;title=CYP2D6+and+tamoxifen:+DNA+matters+in+breast+cancer&amp;author=JM+Hoskins&amp;author=LA+Carey&amp;author=HL+McLeod&amp;volume=9&amp;publication_year=2009&amp;pages=576-586&amp;pmid=19629072&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al.  Genome-wide association study identifies novel breast cancer susceptibility loci. <span><span class="ref-journal">Nature. </span>2007;<span class="ref-vol">447</span>:1087–1093.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2714974/">PMC free article</a>]</span> [<a href="/pubmed/17529967" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Genome-wide+association+study+identifies+novel+breast+cancer+susceptibility+loci&amp;author=DF+Easton&amp;author=KA+Pooley&amp;author=AM+Dunning&amp;author=PD+Pharoah&amp;author=D+Thompson&amp;volume=447&amp;publication_year=2007&amp;pages=1087-1093&amp;pmid=17529967&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, et al.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:870–874.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3493132/">PMC free article</a>]</span> [<a href="/pubmed/17529973" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=A+genome-wide+association+study+identifies+alleles+in+FGFR2+associated+with+risk+of+sporadic+postmenopausal+breast+cancer&amp;author=DJ+Hunter&amp;author=P+Kraft&amp;author=KB+Jacobs&amp;author=DG+Cox&amp;author=M+Yeager&amp;volume=39&amp;publication_year=2007&amp;pages=870-874&amp;pmid=17529973&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, et al.  Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:865–869.</span> [<a href="/pubmed/17529974" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Common+variants+on+chromosomes+2q35+and+16q12+confer+susceptibility+to+estrogen+receptor-positive+breast+cancer&amp;author=SN+Stacey&amp;author=A+Manolescu&amp;author=P+Sulem&amp;author=T+Rafnar&amp;author=J+Gudmundsson&amp;volume=39&amp;publication_year=2007&amp;pages=865-869&amp;pmid=17529974&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al.  Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>:324–328.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2754845/">PMC free article</a>]</span> [<a href="/pubmed/19219042" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Genome-wide+association+study+identifies+a+new+breast+cancer+susceptibility+locus+at+6q25.1&amp;author=W+Zheng&amp;author=J+Long&amp;author=YT+Gao&amp;author=C+Li&amp;author=Y+Zheng&amp;volume=41&amp;publication_year=2009&amp;pages=324-328&amp;pmid=19219042&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Long J, Cai Q, Shu XO, Qu S, Li C, Zheng Y, et al.  Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. <span><span class="ref-journal">PLoS Genet. </span>2010;<span class="ref-vol">6</span>:e1001002.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2891809/">PMC free article</a>]</span> [<a href="/pubmed/20585626" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=Identification+of+a+functional+genetic+variant+at+16q12.1+for+breast+cancer+risk:+results+from+the+Asia+Breast+Cancer+Consortium&amp;author=J+Long&amp;author=Q+Cai&amp;author=XO+Shu&amp;author=S+Qu&amp;author=C+Li&amp;volume=6&amp;publication_year=2010&amp;pages=e1001002&amp;pmid=20585626&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, et al.  A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1) <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>:579–584.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2928646/">PMC free article</a>]</span> [<a href="/pubmed/19330030" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=A+multistage+genome-wide+association+study+in+breast+cancer+identifies+two+new+risk+alleles+at+1p11.2+and+14q24.1+(RAD51L1)&amp;author=G+Thomas&amp;author=KB+Jacobs&amp;author=P+Kraft&amp;author=M+Yeager&amp;author=S+Wacholder&amp;volume=41&amp;publication_year=2009&amp;pages=579-584&amp;pmid=19330030&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al.  Genome-wide association study identifies five new breast cancer susceptibility loci. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>:504–507.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3632836/">PMC free article</a>]</span> [<a href="/pubmed/20453838" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Genome-wide+association+study+identifies+five+new+breast+cancer+susceptibility+loci&amp;author=C+Turnbull&amp;author=S+Ahmed&amp;author=J+Morrison&amp;author=D+Pernet&amp;author=A+Renwick&amp;volume=42&amp;publication_year=2010&amp;pages=504-507&amp;pmid=20453838&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, et al.  A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>:885–892.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3130795/">PMC free article</a>]</span> [<a href="/pubmed/20852631" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=A+locus+on+19p13+modifies+risk+of+breast+cancer+in+BRCA1+mutation+carriers+and+is+associated+with+hormone+receptor-negative+breast+cancer+in+the+general+population&amp;author=AC+Antoniou&amp;author=X+Wang&amp;author=ZS+Fredericksen&amp;author=L+McGuffog&amp;author=R+Tarrell&amp;volume=42&amp;publication_year=2010&amp;pages=885-892&amp;pmid=20852631&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Azzato EM, Tyrer J, Fasching PA, Beckmann MW, Ekici AB, Schulz-Wendtland R, et al.  Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. <span><span class="ref-journal">J Natl Cancer Inst. </span>2010;<span class="ref-vol">102</span>:650–662.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2864289/">PMC free article</a>]</span> [<a href="/pubmed/20308648" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=Association+between+a+germline+OCA2+polymorphism+at+chromosome+15q13.1+and+estrogen+receptor-negative+breast+cancer+survival&amp;author=EM+Azzato&amp;author=J+Tyrer&amp;author=PA+Fasching&amp;author=MW+Beckmann&amp;author=AB+Ekici&amp;volume=102&amp;publication_year=2010&amp;pages=650-662&amp;pmid=20308648&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Azzato EM, Pharoah PD, Harrington P, Easton DF, Greenberg D, Caporaso NE, et al.  A genome-wide association study of prognosis in breast cancer. <span><span class="ref-journal">Cancer Epidemiol Biomarkers Prev. </span>2010;<span class="ref-vol">19</span>:1140–1143.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2852476/">PMC free article</a>]</span> [<a href="/pubmed/20332263" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Epidemiol+Biomarkers+Prev&amp;title=A+genome-wide+association+study+of+prognosis+in+breast+cancer&amp;author=EM+Azzato&amp;author=PD+Pharoah&amp;author=P+Harrington&amp;author=DF+Easton&amp;author=D+Greenberg&amp;volume=19&amp;publication_year=2010&amp;pages=1140-1143&amp;pmid=20332263&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Shu XO, Zheng Y, Cai H, Gu K, Chen Z, Zheng W, et al.  Soy food intake and breast cancer survival. <span><span class="ref-journal">JAMA. </span>2009;<span class="ref-vol">302</span>:2437–2443.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2874068/">PMC free article</a>]</span> [<a href="/pubmed/19996398" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Soy+food+intake+and+breast+cancer+survival&amp;author=XO+Shu&amp;author=Y+Zheng&amp;author=H+Cai&amp;author=K+Gu&amp;author=Z+Chen&amp;volume=302&amp;publication_year=2009&amp;pages=2437-2443&amp;pmid=19996398&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Zheng W, Chow WH, Yang G, Jin F, Rothman N, Blair A, et al.  The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. <span><span class="ref-journal">Am J Epidemiol. </span>2005;<span class="ref-vol">162</span>:1123–1131.</span> [<a href="/pubmed/16236996" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Epidemiol&amp;title=The+Shanghai+Women's+Health+Study:+rationale,+study+design,+and+baseline+characteristics&amp;author=W+Zheng&amp;author=WH+Chow&amp;author=G+Yang&amp;author=F+Jin&amp;author=N+Rothman&amp;volume=162&amp;publication_year=2005&amp;pages=1123-1131&amp;pmid=16236996&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Chen X, Lu W, Zheng Y, Gu K, Chen Z, Zheng W, et al.  Exercise, tea consumption, and depression among breast cancer survivors. <span><span class="ref-journal">J Clin Oncol. </span>2010;<span class="ref-vol">28</span>:991–998.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2834436/">PMC free article</a>]</span> [<a href="/pubmed/20048185" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Exercise,+tea+consumption,+and+depression+among+breast+cancer+survivors&amp;author=X+Chen&amp;author=W+Lu&amp;author=Y+Zheng&amp;author=K+Gu&amp;author=Z+Chen&amp;volume=28&amp;publication_year=2010&amp;pages=991-998&amp;pmid=20048185&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Epplein M, Zheng Y, Zheng W, Chen Z, Gu K, Penson D, et al.  Quality of life after breast cancer diagnosis and survival. <span><span class="ref-journal">J Clin Oncol. </span>2011;<span class="ref-vol">29</span>:406–412.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3058286/">PMC free article</a>]</span> [<a href="/pubmed/21172892" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Quality+of+life+after+breast+cancer+diagnosis+and+survival&amp;author=M+Epplein&amp;author=Y+Zheng&amp;author=W+Zheng&amp;author=Z+Chen&amp;author=K+Gu&amp;volume=29&amp;publication_year=2011&amp;pages=406-412&amp;pmid=21172892&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Purcell S. PLINK. <span><span class="ref-journal">http://pngu mgh harvard edu/~purcell/plink/ </span>2012</span> Available from: URL:  <a href="http://pngu.mgh.harvard.edu/~purcell/plink/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://pngu.mgh.harvard.edu/~purcell/plink/</a> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=http://pngu+mgh+harvard+edu/~purcell/plink/&amp;title=PLINK&amp;author=S+Purcell&amp;publication_year=2012&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">81</span>:559–575.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1950838/">PMC free article</a>]</span> [<a href="/pubmed/17701901" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=PLINK:+a+tool+set+for+whole-genome+association+and+population-based+linkage+analyses&amp;author=S+Purcell&amp;author=B+Neale&amp;author=K+Todd-Brown&amp;author=L+Thomas&amp;author=MA+Ferreira&amp;volume=81&amp;publication_year=2007&amp;pages=559-575&amp;pmid=17701901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Thacker J. The RAD51 gene family, genetic instability and cancer. <span><span class="ref-journal">Cancer Lett. </span>2005;<span class="ref-vol">219</span>:125–135.</span> [<a href="/pubmed/15723711" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Lett&amp;title=The+RAD51+gene+family,+genetic+instability+and+cancer&amp;author=J+Thacker&amp;volume=219&amp;publication_year=2005&amp;pages=125-135&amp;pmid=15723711&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Yoo S, McKee BD. Overexpression of Drosophila Rad51 protein (DmRad51) disrupts cell cycle progression and leads to apoptosis. <span><span class="ref-journal">Chromosoma. </span>2004;<span class="ref-vol">113</span>:92–101.</span> [<a href="/pubmed/15257466" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chromosoma&amp;title=Overexpression+of+Drosophila+Rad51+protein+(DmRad51)+disrupts+cell+cycle+progression+and+leads+to+apoptosis&amp;author=S+Yoo&amp;author=BD+McKee&amp;volume=113&amp;publication_year=2004&amp;pages=92-101&amp;pmid=15257466&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Takaku M, Machida S, Hosoya N, Nakayama S, Takizawa Y, Sakane I, et al.  Recombination activator function of the novel R. <span><span class="ref-journal">J Biol Chem. </span>2009;<span class="ref-vol">284</span>:14326–14336.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2682881/">PMC free article</a>]</span> [<a href="/pubmed/19329439" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Recombination+activator+function+of+the+novel+R&amp;author=M+Takaku&amp;author=S+Machida&amp;author=N+Hosoya&amp;author=S+Nakayama&amp;author=Y+Takizawa&amp;volume=284&amp;publication_year=2009&amp;pages=14326-14336&amp;pmid=19329439&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Cox N, Nicolae DL, Dolan ME, Gamazon ER. SCAN: SNP and CNV Annotation Database. <span><span class="ref-journal">http://www scandb org/newinterface/about html. </span>2012</span> Available from: URL:  <a href="http://www.scandb.org/newinterface/about.html" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.scandb.org/newinterface/about.html</a>. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=http://www+scandb+org/newinterface/about+html&amp;title=SCAN:+SNP+and+CNV+Annotation+Database&amp;author=N+Cox&amp;author=DL+Nicolae&amp;author=ME+Dolan&amp;author=ER+Gamazon&amp;publication_year=2012&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Gamazon ER, Zhang W, Konkashbaev A, Duan S, Kistner EO, Nicolae DL, et al.  SCAN: SNP and copy number annotation. <span><span class="ref-journal">Bioinformatics. </span>2010;<span class="ref-vol">26</span>:259.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2852202/">PMC free article</a>]</span> [<a href="/pubmed/19933162" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=SCAN:+SNP+and+copy+number+annotation&amp;author=ER+Gamazon&amp;author=W+Zhang&amp;author=A+Konkashbaev&amp;author=S+Duan&amp;author=EO+Kistner&amp;volume=26&amp;publication_year=2010&amp;pages=259&amp;pmid=19933162&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Jia T, Liu YE, Liu J, Shi YE. Stimulation of breast cancer invasion and metastasis by synuclein gamma. <span><span class="ref-journal">Cancer Res. </span>1999;<span class="ref-vol">59</span>:742–747.</span> [<a href="/pubmed/9973226" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Stimulation+of+breast+cancer+invasion+and+metastasis+by+synuclein+gamma&amp;author=T+Jia&amp;author=YE+Liu&amp;author=J+Liu&amp;author=YE+Shi&amp;volume=59&amp;publication_year=1999&amp;pages=742-747&amp;pmid=9973226&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Wu K, Weng Z, Tao Q, Lin G, Wu X, Qian H, et al.  Stage-specific expression of breast cancer-specific gene gamma-synuclein. <span><span class="ref-journal">Cancer Epidemiol Biomarkers Prev. </span>2003;<span class="ref-vol">12</span>:920–925.</span> [<a href="/pubmed/14504205" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Epidemiol+Biomarkers+Prev&amp;title=Stage-specific+expression+of+breast+cancer-specific+gene+gamma-synuclein&amp;author=K+Wu&amp;author=Z+Weng&amp;author=Q+Tao&amp;author=G+Lin&amp;author=X+Wu&amp;volume=12&amp;publication_year=2003&amp;pages=920-925&amp;pmid=14504205&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Liu J, Spence MJ, Zhang YL, Jiang Y, Liu YE, Shi YE. Transcriptional suppression of synuclein gamma (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M. <span><span class="ref-journal">Breast Cancer Res Treat. </span>2000;<span class="ref-vol">62</span>:99–107.</span> [<a href="/pubmed/11016747" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Breast+Cancer+Res+Treat&amp;title=Transcriptional+suppression+of+synuclein+gamma+(SNCG)+expression+in+human+breast+cancer+cells+by+the+growth+inhibitory+cytokine+oncostatin+M&amp;author=J+Liu&amp;author=MJ+Spence&amp;author=YL+Zhang&amp;author=Y+Jiang&amp;author=YE+Liu&amp;volume=62&amp;publication_year=2000&amp;pages=99-107&amp;pmid=11016747&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="element-citation">Singh H, Sekinger EA, Gross DS. Chromatin and cancer: causes and consequences. <span><span class="ref-journal">J Cell Biochem Suppl. </span>2000 Suppl 35:61–68.</span> [<a href="/pubmed/11389533" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Biochem+Suppl&amp;title=Chromatin+and+cancer:+causes+and+consequences&amp;author=H+Singh&amp;author=EA+Sekinger&amp;author=DS+Gross&amp;publication_year=2000&amp;pages=61-68&amp;pmid=11389533&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36. <span class="element-citation">Tanaka K, Tsurumi C. The 26S proteasome: subunits and functions. <span><span class="ref-journal">Mol Biol Rep. </span>1997;<span class="ref-vol">24</span>:3–11.</span> [<a href="/pubmed/9228274" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Biol+Rep&amp;title=The+26S+proteasome:+subunits+and+functions&amp;author=K+Tanaka&amp;author=C+Tsurumi&amp;volume=24&amp;publication_year=1997&amp;pages=3-11&amp;pmid=9228274&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">37. <span class="element-citation">Luqmani YA, Al AA, Al BM, Abraham G, El ZM. Modification of gene expression induced by siRNA targeting of estrogen receptor alpha in MCF7 human breast cancer cells. <span><span class="ref-journal">Int J Oncol. </span>2009;<span class="ref-vol">34</span>:231–242.</span> [<a href="/pubmed/19082494" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Oncol&amp;title=Modification+of+gene+expression+induced+by+siRNA+targeting+of+estrogen+receptor+alpha+in+MCF7+human+breast+cancer+cells&amp;author=YA+Luqmani&amp;author=AA+Al&amp;author=BM+Al&amp;author=G+Abraham&amp;author=ZM+El&amp;volume=34&amp;publication_year=2009&amp;pages=231-242&amp;pmid=19082494&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">38. <span class="element-citation">Almond JB, Cohen GM. The proteasome: a novel target for cancer chemotherapy. <span><span class="ref-journal">Leukemia. </span>2002;<span class="ref-vol">16</span>:433–443.</span> [<a href="/pubmed/11960320" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=The+proteasome:+a+novel+target+for+cancer+chemotherapy&amp;author=JB+Almond&amp;author=GM+Cohen&amp;volume=16&amp;publication_year=2002&amp;pages=433-443&amp;pmid=11960320&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">39. <span class="element-citation">Zheng W, Wen W, Gao YT, Shyr Y, Zheng Y, Long J, et al.  Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. <span><span class="ref-journal">J Natl Cancer Inst. </span>2010;<span class="ref-vol">102</span>:972–981.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2897876/">PMC free article</a>]</span> [<a href="/pubmed/20484103" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=Genetic+and+clinical+predictors+for+breast+cancer+risk+assessment+and+stratification+among+Chinese+women&amp;author=W+Zheng&amp;author=W+Wen&amp;author=YT+Gao&amp;author=Y+Shyr&amp;author=Y+Zheng&amp;volume=102&amp;publication_year=2010&amp;pages=972-981&amp;pmid=20484103&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3294129&amp;issue-id=206231&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140146739591520title">Abstract</a></li><li><a href="#S1title">INTRODUCTION</a></li><li><a href="#S2title">METHODS</a></li><li><a href="#S6title">RESULTS</a></li><li><a href="#S7title">DISCUSSION</a></li><li><a href="#SMtitle">Supplementary Material</a></li><li><a href="#S8title">Acknowledgement</a></li><li><a href="#idm140146780213120title">Abbreviations</a></li><li><a href="#idm140146778031536title">Footnotes</a></li><li><a href="#idm140146776736112title">Reference List</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3294129/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3294129/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3294129/pdf/nihms349335.pdf">PDF (1.1M)</a></li> | <li><a href="#" data-citationid="PMC3294129" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3294129%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3294129%2F&amp;text=Novel%20Genetic%20Markers%20of%20Breast%20Cancer%20Survival%20Identified%20by%20a%20Genome-Wide%20Association%20Study" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3294129%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="22232737" data-aiid="3294129" data-aid="3294129" data-iid="206231" data-domainid="319" data-domain="nihpa" data-accid="PMC3294129" data-md5="d1a30f7415a92321f050c91ba60ba657"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T08:24:34-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal106&amp;ncbi_phid=CE8DCF04DD53B98100000000020B015C&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3294129%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3294129/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>